论文部分内容阅读
有关部门计划“十二五”期间投向生物医药产业的重大新药研发、创制领域专项资金将在400亿元左右,比“十一五”期间翻了一番多。在具体支持领域中,对生物制品研发的支持力度明显加大。
Relevant departments plan to launch major new drug research and development projects in the biomedical industry during the “12th Five-Year Plan” period, with special funds in the field of creation of about 40 billion yuan more than doubled during the “11th Five-Year Plan” period. In specific areas of support, the support for research and development of biological products has been significantly increased.